July 10 (Reuters) - Recce Pharmaceuticals Ltd (RCE) :
- RECCE PHARMACEUTICALS LTD - R327 DEMONSTRATES 99.99999% LOG REDUCTION IN A. BAUMANNII
- RECCE PHARMACEUTICALS ANNOUNCES POSITIVE PRECLINICAL EFFICACY DATA AGAINST WHO PRIORITY PATHOGEN ACINETOBACTER BAUMANNII
July 10 (Reuters) - Recce Pharmaceuticals Ltd (RCE) : RECCE...
Add to My Watchlist
What is My Watchlist?